NextCure, Inc. (NXTC) NASDAQ
3.44
+0.06(+1.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.44
+0.06(+1.78%)
Currency In USD
| Market Cap | 40.33M |
| Enterprise Value | 18.5M |
| P/E Ratio | -0.33 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.67 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.44 |
| Return On Equity | -1.87 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.19M |
| EBITDA | -55.43M |
| Net Income | -55.84M |
| Diluted EPS | -19.65 |
| Total Cash | 29.74M |
| Total Cash/Share | 5.68 |
| Total Debt | 3.88M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 4.61 |
| Book Value Per Share | 5.1 |
| 52-Week Change | -40.28 |
| 52-Week High | 15.74 |
| 52-Week Low | 2.83 |
| Moving Average 50 Days | 9.9 |
| Moving Average 200 Days | 9.99 |
| Average Volume | 64,404 |
| Shares Outstanding | 2.68M |
| % Held by Institutions | 61.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 14, 2025 |